MedTrace Logo

Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment

NCT04764604 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-08-01

Study results available
· View outcomes & findings →

Summary

A feasibility study to identify the immediate effect on the voices of patients with voice disorders (muscle tension dysphonia, vocal fold palsy or presbylaryngis) produced by exercising with Acapella Choice as a form of semioccluded vocal tract exercise (SOVTE).

Conditions

  • Muscle Tension Dysphonia
  • Vocal Fold Palsy
  • Vocal Cord Paralysis
  • Presbylarynx
  • Dysphonia

Interventions

DEVICE

Acapella Choice

3 minutes of exercise consisting of blowing through the device (on setting '5') and phonating at the same time.

DEVICE

Tube-in-water

3 minutes of exercise consisting of blowing through a silicone tube (10mm internal diameter) submerged in 5 cm of water whilst phonating at the same time.

Sponsors & Collaborators

  • Smiths Medical, ASD, Inc.

    collaborator INDUSTRY

  • University College, London

    lead OTHER

Principal Investigators

  • Brian Saccente-Kennedy, MSc · University College London Hospitals

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-14
Primary Completion
2021-11-29
Completion
2021-11-29
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04764604 on ClinicalTrials.gov